Amina Z. Haggag

Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study

Neeta B. Amin, Robert Frederich, Nikolaos Tsamandouras et al. · Diabetes Obesity and Metabolism · 2024 · 17 citations · Full text

Risk of COVID-19 after natural infection or vaccination

Anne-Marie Rick, Matthew B. Laurens, Ying Huang et al. · EBioMedicine · 2023 · 13 citations · Full text

Non‐clinical and first‐in‐human characterization of <scp>ECC5004</scp> / <scp>AZD5004</scp> , a novel once‐daily, oral small‐molecule <scp>GLP</scp> ‐1 receptor agonist

Amina Z. Haggag, Jianfeng Xu, Laurie Butcher et al. · Diabetes Obesity and Metabolism · 2024 · 12 citations · Full text